Mycodern Spolka Akcyjna
MCD | WAR
Overview
Corporate Details
- ISIN(s):
- PLMDNPL00013 (+3 more)
- LEI:
- 25940087YXP4K8ENAO45
- Country:
- Poland
- Address:
- GDAŃSK JAŚKOWA DOLINA 132/20, 80-286 GDAŃSK
- Website:
- http://www.mycodern.com
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Mycodern Spolka Akcyjna specializes in medical innovations, particularly in dermatology and fungal infection treatments. The company combines advanced research with state-of-the-art production to create effective healthcare solutions. Its commitment to addressing unmet medical needs has positioned it as a trusted name in the biotechnology industry. Mycodern aims to improve patient outcomes through innovative and accessible treatments for skin-related conditions.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-04-08 15:20 |
Transaction in Own Shares
Korekta raportu ESPI nr 4/2024 - Zakończenie emisji oraz przydział akcji serii …
|
Polish | 2.1 KB | |
| 2024-03-29 20:50 |
Transaction in Own Shares
Zakończenie emisji oraz przydział akcji serii E - Content (PL)
|
Polish | 1.5 KB | |
| 2024-01-23 23:32 |
Regulatory News Service
Zawarcie ramowej umowy w zakresie wytwarzania i dostawy żelków - Content (PL)
|
Polish | 1.2 KB | |
| 2024-01-23 23:29 |
Prospectus
Dokument Ofertowy - MCD
|
Polish | 388.9 KB | |
| 2024-01-23 23:29 |
Share Issue/Capital Change
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
|
Polish | 1.2 KB | |
| 2024-01-23 17:20 |
Regulatory News Service
Zawarcie umowy o współpracy - Content (PL)
|
Polish | 1.7 KB | |
| 2023-12-31 20:02 |
Declaration of Voting Results & Voting Rights Announcements
zal01_Fundacja-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
|
Polish | 183.3 KB | |
| 2023-12-31 20:02 |
Declaration of Voting Results & Voting Rights Announcements
zal02_MP-zawiadomienie_-_art._69_ustawy_o_ofercie-29.12.2023.pdf
|
Polish | 181.8 KB | |
| 2023-12-31 20:02 |
Declaration of Voting Results & Voting Rights Announcements
Zawiadomienia akcjonariuszy w sprawie zmiany udziału w głosach - Content (PL)
|
Polish | 637 bytes | |
| 2023-12-29 22:27 |
Regulatory News Service
MCD - dokument ofertowy (seria E)
|
Polish | 444.1 KB | |
| 2023-12-29 22:27 |
Regulatory News Service
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
|
Polish | 728 bytes | |
| 2023-11-29 14:02 |
Regulatory News Service
MCD - Dokument ofertowy
|
Polish | 400.2 KB | |
| 2023-11-29 14:02 |
Regulatory News Service
Publikacja ogłoszenia o ofercie objęcia akcji serii E przez akcjonariuszy posia…
|
Polish | 1.5 KB | |
| 2023-10-23 21:09 |
Directors' Dealings
Formularz zapisu - seria E
|
Polish | 168.3 KB | |
| 2023-10-23 21:09 |
Regulatory News Service
Dokument Ofertowy - seria E
|
Polish | 353.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Swedish Orphan Biovitrum | Sweden | SOBI | |
|
SynAct Pharma | Sweden | SYNACT | |
|
SYNAIRGEN PLC | United Kingdom | SNG | |
|
Synthaverse S.A. | Poland | BML | |
|
Taurus Energy AB | Sweden | TAUR B | |
| Themis GREN Ltd. | Israel | TMIS | ||
|
Theradiag | France | ALTER | |
|
Theranexus | France | ALTHX | |
|
Thor Medical ASA | Norway | NANOV | |
|
TME Pharma N.V. | Germany | ALTME |